Data from the CDSCO reveals that numerous MSME pharmaceutical companies in India are producing substandard drugs, failing to ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

Emcure Pharmaceuticals, Honasa Consumers, and Reliance Home Finance will be among 164 companies to post earnings reports for the January-March quarter on May 22 ...

Dr. Neema Bisht shared her inspiring journey from a practicing dentist to becoming a successful TEDx speaker, entrepreneur.

Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...

Analysts believe that recent product launches in India will further solidify Sun Pharmas leading position in the branded ...

Notably, the companys EBITDA surged by 16.5 percent, increasing from Rs 586.3 crore to Rs 683.2 crore from previous year.

Mankind Pharma’s Q4 profit declined 10.7% even as revenue grew 27% YoY. Management cited BSV integration, chronic therapy ...

For the quarter ended March 31, the company posted revenue of ₹3,079 crore, up 27% year-on-year, with adjusted EBITDA margin ...

Cumberland Pharmaceuticals' CEO discusses how potential tariffs on drugs could affect the Nashville-based company's business.

Having posted record annual revenue of $NZ208 million, AFT Pharmaceuticals says it can achieve further 50% growth over the ...

BridgeBio Pharma, Inc.'s stock soars on Attruby's launch and licensing deals. Click for more on BBIO growth, competition, and ...